AUGMENT: A Phase III Study of Lenalidomide Plus Rituximab Versus Placebo Plus Rituximab in Relapsed or Refractory Indolent Lymphoma von Leonard, John P, Trneny, Marek, Izutsu, Koji, Fowler, Nathan H, Hong, Xiaonan, Zhu, Jun, Zhang, Huilai, Offner, Fritz, Scheliga, Adriana, Nowakowski, Grzegorz S, Pinto, Antonio, Re, Francesca, Fogliatto, Laura Maria, Scheinberg, Phillip, Flinn, Ian W, Moreira, Claudia, Cabeçadas, José, Liu, David, Kalambakas, Stacey, Fustier, Pierre, Wu, Chengqing, Gribben, John G

Volltext

Follicular lymphoma grade 3B: low grade, high grade or should we skip the grade? von Mulvey, Erin, Leonard, John P

Volltext

Monoclonal Antibody Therapy for B-Cell Non-Hodgkin's Lymphoma von Cheson, Bruce D, Leonard, John P

Volltext

Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour act... von Wilson, Wyndham H, Prof, O'Connor, Owen A, Prof, Czuczman, Myron S, Prof, LaCasce, Ann S, MD, Gerecitano, John F, MD, Leonard, John P, Prof, Tulpule, Anil, MD, Dunleavy, Kieron, MD, Xiong, Hao, PhD, Chiu, Yi-Lin, PhD, Cui, Yue, PhD, Busman, Todd, MS, Elmore, Steven W, PhD, Rosenberg, Saul H, PhD, Krivoshik, Andrew P, MD, Enschede, Sari H, MD, Humerickhouse, Rod A, MD

Volltext

Practical Implications of the 2016 Revision of the World Health Organization Classification of Lymphoid and Myeloid Neoplasms and Acute Leukemia von Leonard, John P, Martin, Peter, Roboz, Gail J

Volltext

Clinical and Biological Subtypes of B-cell Lymphoma Revealed by Microenvironmental Signatures von Kotlov, Nikita, Bagaev, Alexander, Revuelta, Maria V, Phillip, Jude M, Cacciapuoti, Maria Teresa, Antysheva, Zoya, Svekolkin, Viktor, Tikhonova, Ekaterina, Miheecheva, Natalia, Kuzkina, Natalia, Nos, Grigorii, Tabbo, Fabrizio, Frenkel, Felix, Ghione, Paola, Tsiper, Maria, Almog, Nava, Fowler, Nathan, Melnick, Ari M, Leonard, John P, Inghirami, Giorgio, Cerchietti, Leandro

Volltext

Efficacy and safety results from CheckMate 140, a phase 2 study of nivolumab for relapsed/refractory follicular lymphoma von Armand, Philippe, Janssens, Ann, Gritti, Giuseppe, Radford, John, Timmerman, John, Pinto, Antonio, Mercadal Vilchez, Santiago, Johnson, Peter, Cunningham, David, Leonard, John P., Rodig, Scott J., Martín-Regueira, Patricia, Sumbul, Anne, Samakoglu, Selda, Tang, Hao, Ansell, Stephen M.

Volltext

Diabetes care management patterns before and after a cancer diagnosis: A SEER‐Medicare matched cohort study von Pinheiro, Laura C., Soroka, Orysya, Kern, Lisa M., Leonard, John P., Safford, Monika M.

Volltext

Addition of Lenalidomide to R-CHOP Improves Outcomes in Newly Diagnosed Diffuse Large B-Cell Lymphoma in a Randomized Phase II US Intergroup Study ECOG-ACRIN E1412 von Nowakowski, Grzegorz S, Hong, Fangxin, Scott, David W, Macon, William R, King, Rebecca L, Habermann, Thomas M, Wagner-Johnston, Nina, Casulo, Carla, Wade, James L, Nagargoje, Gauri G, Reynolds, C M, Cohen, Jonathon B, Khan, Nadia, Amengual, Jennifer E, Richards, Kristy L, Little, R F, Leonard, John P, Friedberg, Jonathan W, Kostakoglu, Lale, Kahl, Brad S, Witzig, Thomas E

Volltext

US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose-Positron Emission Tomography Imaging: Southwest Oncology... von Press, Oliver W, Li, Hongli, Schöder, Heiko, Straus, David J, Moskowitz, Craig H, LeBlanc, Michael, Rimsza, Lisa M, Bartlett, Nancy L, Evens, Andrew M, Mittra, Erik S, LaCasce, Ann S, Sweetenham, John W, Barr, Paul M, Fanale, Michelle A, Knopp, Michael V, Noy, Ariela, Hsi, Eric D, Cook, James R, Lechowicz, Mary Jo, Gascoyne, Randy D, Leonard, John P, Kahl, Brad S, Cheson, Bruce D, Fisher, Richard I, Friedberg, Jonathan W

Volltext

Five-year follow-up of lenalidomide plus rituximab as initial treatment of mantle cell lymphoma von Ruan, Jia, Martin, Peter, Christos, Paul, Cerchietti, Leandro, Tam, Wayne, Shah, Bijal, Schuster, Stephen J., Rodriguez, Amelyn, Hyman, David, Calvo-Vidal, Maria Nieves, Smith, Sonali M., Svoboda, Jakub, Furman, Richard R., Coleman, Morton, Leonard, John P.

Volltext

A phase 1 trial of ibrutinib plus palbociclib in previously treated mantle cell lymphoma von Martin, Peter, Bartlett, Nancy L., Blum, Kristie A., Park, Steven, Maddocks, Kami, Ruan, Jia, Ridling, LeAnn, Dittus, Christopher, Chen, Zhengming, Huang, Xiangao, Inghirami, Giorgio, DiLiberto, Maurizio, Chen-Kiang, Selina, Leonard, John P.

Volltext

CALGB 50604: risk-adapted treatment of nonbulky early-stage Hodgkin lymphoma based on interim PET von Straus, David J., Jung, Sin-Ho, Pitcher, Brandelyn, Kostakoglu, Lale, Grecula, John C., Hsi, Eric D., Schöder, Heiko, Popplewell, Leslie L., Chang, Julie E., Moskowitz, Craig H., Wagner-Johnston, Nina, Leonard, John P., Friedberg, Jonathan W., Kahl, Brad S., Cheson, Bruce D., Bartlett, Nancy L.

Volltext

Rationally designed BCL6 inhibitors target activated B cell diffuse large B cell lymphoma von Cardenas, Mariano G, Yu, Wenbo, Beguelin, Wendy, Teater, Matthew R, Geng, Huimin, Goldstein, Rebecca L, Oswald, Erin, Hatzi, Katerina, Yang, Shao-Ning, Cohen, Joanna, Shaknovich, Rita, Vanommeslaeghe, Kenno, Cheng, Huimin, Liang, Dongdong, Cho, Hyo Je, Abbott, Joshua, Tam, Wayne, Du, Wei, Leonard, John P, Elemento, Olivier, Cerchietti, Leandro, Cierpicki, Tomasz, Xue, Fengtian, MacKerell, Jr, Alexander D, Melnick, Ari M

Volltext

Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma von PIEKARZ, Richard L, FRYE, Robin, REEDER, Craig, JOSKE, David, FIGG, William D, GARDNER, Erin R, STEINBERG, Seth M, JAFFE, Elaine S, STETLER-STEVENSON, Maryalice, LADE, Stephen, FOJO, A. Tito, BATES, Susan E, TURNER, Maria, WRIGHT, John J, ALLEN, Steven L, KIRSCHBAUM, Mark H, ZAIN, Jasmine, PRINCE, H. Miles, LEONARD, John P, GESKIN, Larisa J

Volltext

Bortezomib Plus CHOP-Rituximab for Previously Untreated Diffuse Large B-Cell Lymphoma and Mantle Cell Lymphoma von JIA RUAN, MARTIN, Peter, CHADBURN, Amy, CESARMAN, Ethel, COLEMAN, Morton, LEONARD, John P, FURMAN, Richard R, LEE, Shing M, CHEUNG, Ken, VOSE, Julie M, LACASCE, Ann, MORRISON, Julia, ELSTROM, Rebecca, ELY, Scott

Volltext

CNS-accessible Inhibitor of Glucosylceramide Synthase for Substrate Reduction Therapy of Neuronopathic Gaucher Disease von Marshall, John, Sun, Ying, Bangari, Dinesh S, Budman, Eva, Park, Hyejung, Nietupski, Jennifer B, Allaire, Amy, Cromwell, Mary A, Wang, Bing, Grabowski, Gregory A, Leonard, John P, Cheng, Seng H

Volltext

Effects of sun angle, lunar illumination, and diurnal temperature on temporal movement rates of sympatric ocelots and bobcats in South Texas von Leonard, John P, Tewes, Michael E, Lombardi, Jason V, Wester, David W, Campbell, Tyler A

Volltext

Outcome of Deferred Initial Therapy in Mantle-Cell Lymphoma von MARTIN, Peter, CHADBURN, Amy, MELNICK, Ari, KNOWLES, Daniel M, CHEN-KIANG, Selina, COLEMAN, Morton, LEONARD, John P, CHRISTOS, Paul, WEIL, Karen, FURMAN, Richard R, JIA RUAN, ELSTROM, Rebecca, NIESVIZKY, Ruben, ELY, Scott, DILIBERTO, Maurizio

Volltext

Human iPSC-derived astrocytes generated from donors with globoid cell leukodystrophy display phenotypes associated with disease von Lieberman, Richard, Cortes, Leslie K, Gao, Grace, Park, Hyejung, Wang, Bing, Jones, Patrick L, Hunter, R. Bridge, Leonard, John P, Barker, Robert H

Volltext